Extracorporeal Membrane Oxygenation Support for Bilateral Sequential Lung Transplantation in Respiratory Failure Patients.
Trial Snapshot
- Phase
- Not Applicable
- Enrollment
- 10
- Locations
- 1
- Primary Endpoint
- 6 months and one year survival after lung transplatn.
Study Overview
Brief Summary
Survival after cadaveric lung transplantation in recipients depended on ventilation support prior to transplantation has been reported to have relative high surgical mortality and morbidity rate. The objectives of this study were to describe the short-term outcomes of bilateral sequential lung transplantation under extracorporeal membrane oxygenation (ECMO) support in a consecutive series of patients who depended on noninvasive and invasive ventilation support preoperatively .
Detailed Description
The one-year survival rate and postoperative pulmonary functional results will be reported in this study.
Study Design
- Study Type
- Observational
- Observational Model
- Case Control
- Time Perspective
- Retrospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •respiratory patients depended on ventilator supports prior to lung transplant
Exclusion Criteria
- •non-cardaveric lung transplant
Outcomes
Primary Outcomes
6 months and one year survival after lung transplatn.
Time Frame: 6 months and one year posttransplant
Secondary Outcomes
- Pulmonary function results, at baseline and posttransplant 1, 3, and 6 months.(baseline, post-op 1,3, and 6 months)
